Axonics Modulation Technologies

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXNX and other ETFs, options, and stocks.

About AXNX

Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. 

CEO
Raymond Wayne Cohen
CEORaymond Wayne Cohen
Employees
517
Employees517
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
2012
Founded2012
Employees
517
Employees517

AXNX Key Statistics

Market cap
3.25B
Market cap3.25B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
411.11K
Average volume411.11K
High today
$66.00
High today$66.00
Low today
$64.58
Low today$64.58
Open price
$65.19
Open price$65.19
Volume
116.29K
Volume116.29K
52 Week high
$79.92
52 Week high$79.92
52 Week low
$38.41
52 Week low$38.41

Analyst ratings

80%

of 10 ratings
Buy
80%
Hold
20%
Sell
0%

AXNX Earnings

-$0.63
-$0.42
-$0.21
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, After Hours
ActualExpected Feb 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.